HABA LABORATORIES,INC.
4925・Standard Market・Chemicals
Cosmetics Business (Single Segment)
Manufacturing and sales of cosmetics and health foods based on an unwavering commitment to additive-free formulation
| Period | Current | Previous | Change |
|---|---|---|---|
| Sales (Consolidated, FY2026 ending March 2026) | ¥12,141 million | ¥12,062 million | ↑ |
| Operating Profit (Consolidated, FY2026 ending March 2026) | ¥727 million | ¥590 million | ↑ |
| Ordinary Profit (Consolidated, FY2026 ending March 2026) | ¥708 million | ¥609 million | ↑ |
| Profit Attributable to Owners of Parent (Consolidated, FY2026 ending March 2026) | ¥760 million | ¥577 million | ↑ |
| Operating Margin (FY2026 ending March 2026) | 6.0% | 4.9% | ↑ |
| Equity Ratio (End of FY2026 ending March 2026) | 76.2% | 72.3% | ↑ |
| Earnings Per Share (Consolidated, FY2026 ending March 2026) | ¥201.07 | ¥152.47 | ↑ |
| Cash and Cash Equivalents, Period-End Balance (FY2026 ending March 2026) | ¥5,684 million | ¥4,744 million | ↑ |
| Sales (Full-Year Forecast, FY2027 ending March 2027) | ¥12,800 million | ¥12,141 million | ↑ |
| Operating Profit (Full-Year Forecast, FY2027 ending March 2027) | ¥610 million | ¥727 million | ↓ |
Business Details
The manufacturing and sales business of cosmetics and health foods operated by the Haba Laboratories Group, founded in 1983. All products thoroughly adhere to the "Five Additive-Free" principle, excluding paraben preservatives, petroleum-based surfactants, synthetic fragrances, mineral oil, and tar-based dyes. While Mail Order (Including EC) Channel serves as the primary channel, sales are also conducted through four routes: Wholesale to Department Stores & Directly-Operated Stores (Store Sales Business), Other Wholesale, and directly-operated stores. The company has built an integrated system spanning R&D, manufacturing (both in-house within the group and outsourced), logistics, and sales. Domestic sales account for over 90% of the total, while overseas expansion continues, focused primarily on the Chinese and broader Asian markets.
Recent Overview
Profit structure reforms bore fruit, driving a 23.4% increase in operating profit; the following fiscal year is expected to see a profit decline due to upfront investments
In FY2026 (ending March 2026), sales were largely flat at ¥12,141 million (up 0.7% year on year), but fixed cost reductions from closing four unprofitable stores and suspending operations at and selling the Komoro plant, along with optimized inventory management and a 1.9% reduction in SG&A expenses (¥7,359 million), contributed to operating profit of ¥727 million (up 23.4% year on year) and net profit of ¥760 million (up 31.9% year on year). A gain of ¥132 million on the sale of fixed assets related to the Komoro plant sale was also recorded as extraordinary income. For FY2027 (ending March 2027), sales are projected to reach ¥12,800 million (up 5.4% year on year), while upfront investments in customer base expansion, product development, and IT are expected to result in a significant profit decline, with operating profit of ¥610 million (down 16.1% year on year) and net profit of ¥470 million (down 38.2% year on year). As a subsequent event, effective April 1, 2026, the company absorbed Haba Cosmetics Co., Ltd. through merger, establishing an integrated operational structure spanning logistics through sales.
Key Products
Growth Drivers
- Continued recovery of inbound demand in wholesale to department stores (up 8.7% year on year to ¥1,932 million in FY2026 ending March 2026)
- Improved sales efficiency in overseas wholesale through consolidation of Chinese distributors (Other Wholesale overall up 10.1% year on year to ¥2,895 million)
- Improved profit structure through closure of unprofitable stores and sale of the Komoro plant (SG&A expenses down 1.9%, ¥132 million gain recorded on sale of fixed assets)
- Increased sales and improved LTV among the premium tier (Diamond and Platinum members) resulting from revisions to the Club Haba program
- Strengthened digital promotion targeting the millennial generation (including video content through collaborations with creators)
- New development and launch of foods with function claims and beauty supplements, and the start of rollout of products exclusive to self-selection channels
- Development of new customer segments and sales channels through the launch of a new brand for general distribution ahead of FY2027 (ending March 2027)
- Improved management efficiency through integrated logistics and sales operations following the absorption merger of Haba Cosmetics (April 2026)
Risks
- Declining trend in new customer acquisition in mail order (the resulting decline in sales from the basic tier directly contributed to the primary channel's 2.5% year-on-year decline)
- Suppressed purchasing among the basic tier (Friend and Standard members) due to rising prices and heightened cost-consciousness
- Forecast of a significant profit decline in FY2027 (ending March 2027) due to upfront investment (operating profit of ¥610 million, down 16.1% year on year; net profit of ¥470 million, down 38.2% year on year)
- Intensifying competition in the EC market and rising advertising costs and customer acquisition costs (CPA)
- Declining sales in Other Wholesale (Domestic) due to store closures among major domestic wholesale clients and a decrease in large-lot orders
- Risk of procurement constraints for key raw materials such as squalane and Chishima bamboo grass water (due to fishing restrictions, environmental changes, etc.)
- Impact on inbound demand and overseas business from prolonged geopolitical risk and exchange rate fluctuations
- Risk of personal information leakage (given the large volume of customer information held due to the mail-order-centric business model)
- Risk of additional impairment of fixed assets (the company recorded an impairment loss of ¥1,576 million in FY2024 (ended March 2024))
Last updated: June 19, 2026

